Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "legacy"

135 News Found

Piramal Pharma appoints Amyra Dastur as brand ambassador for lacto calamine range
News | February 19, 2022

Piramal Pharma appoints Amyra Dastur as brand ambassador for lacto calamine range

The brand has added a range of exciting new products especially formulated for oily skin.


Novartis India enters sales and distribution agreement with Dr. Reddy’s
News | February 12, 2022

Novartis India enters sales and distribution agreement with Dr. Reddy’s

Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India


Zimmer Biomet opens customer experience centre in Singapore to drive robotics and MedTech
Medical Device | February 11, 2022

Zimmer Biomet opens customer experience centre in Singapore to drive robotics and MedTech

It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants


GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22
News | February 08, 2022

GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22

EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.


JBCPL to acquire brands from Sanzyme for Rs 628 cr
News | January 26, 2022

JBCPL to acquire brands from Sanzyme for Rs 628 cr

Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise


Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology
News | January 18, 2022

Solvay awards €300k science prize to Prof Katalin Kariko for research in mRNA technology

Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines


Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products
Biotech | January 18, 2022

Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products

As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio


U.S. FDA approves Bristol Myers Squibb’s Orencia
Drug Approval | December 16, 2021

U.S. FDA approves Bristol Myers Squibb’s Orencia

Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant


Baxter acquires Hillrom for US $ 15 billion
News | December 14, 2021

Baxter acquires Hillrom for US $ 15 billion

It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home


Medical devices industry needs reforms:  Mehernosh Daruwalla, Founder & MD, Lotus Surgicals
interviews | November 24, 2021

Medical devices industry needs reforms: Mehernosh Daruwalla, Founder & MD, Lotus Surgicals

The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector